Your browser doesn't support javascript.
loading
Immune status assessment in adult lung transplant candidates.
van Kessel, Diana A; Hoffman, Thijs W; van Velzen-Blad, Heleen; van de Graaf, Ed A; Grutters, Jan C; Rijkers, Ger T.
Afiliación
  • van Kessel DA; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: d.kessel@antoniusziekenhuis.nl.
  • Hoffman TW; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • van Velzen-Blad H; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • van de Graaf EA; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Grutters JC; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Rijkers GT; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands; Department of Science, University College Roosevelt, Middelburg, The Netherlands.
Transpl Immunol ; 40: 31-34, 2017 02.
Article en En | MEDLINE | ID: mdl-27867073
BACKGROUND: Lung transplant recipients have an increased susceptibility to a variety of infections due to immunosuppressive therapy. Current guidelines recommend pneumococcal and other vaccinations, prior to lung transplantation to protect against post-transplant infections, but measurement of the antibody response to vaccination is not advised. Immune status investigation in lung transplant candidates, including the response to pneumococcal polysaccharide vaccination, has not been described. METHODS: Immune status investigation, including measurement of immunoglobulins, complement and the response to 23-valent pneumococcal polysaccharide vaccination (23vPPV) was performed in 81 adult lung transplant candidates. RESULTS: Eighteen patients had low IgG levels and 32 patients had low IgG1 and/or IgG2 levels. After vaccination with 23vPPV the median antibody concentration of all serotypes increased significantly. Fifty-two patients had protective IgG-post-vaccination antibody levels to at least 10 serotypes. Twenty-nine patients had an impaired response to 23vPPV. CONCLUSIONS: In conclusion, a significant proportion of our cohort of lung transplant candidates had one or more abnormalities in the immune status. It is likely that these patients have an increased risk for infections after transplantation. Revaccination, including measurement of antibody response, and possibly antibody replacement therapy should be considered to minimize infection risk.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Inmunoglobulinas / Trasplante de Pulmón / Vacunas Neumococicas / Infecciones Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TRANSPLANTE Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Inmunoglobulinas / Trasplante de Pulmón / Vacunas Neumococicas / Infecciones Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TRANSPLANTE Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos